![Glenn Bartholomew](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Glenn Bartholomew
Keine laufenden Positionen mehr
Karriereverlauf von Glenn Bartholomew
Ehemalige bekannte Positionen von Glenn Bartholomew
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sirigen Group Ltd.
![]() Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality. | Corporate Officer/Principal | 18.11.2009 | - |
Ausbildung von Glenn Bartholomew
University of California, Santa Barbara | Doctorate Degree |
State University of New York College at Geneseo | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sirigen Group Ltd.
![]() Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality. | Process Industries |
- Börse
- Insiders
- Glenn Bartholomew
- Erfahrung